Transdermal delivery of isoniazid and rifampin in guinea pigs by electro-phonophoresis.
Transdermal delivery of isoniazid and rifampin in guinea pigs by electro-phonophoresis.
复制标题
豚鼠体内异烟肼和利福平的电泳透皮给药
DOI:
10.1080/10717544.2016.1267275
复制
发表时间:
2017-11
期刊:
影响因子:
6
通讯作者:
Huang H
中科院分区:
文献类型:
--
作者:
Chen S;Han Y;Yu D;Huo F;Wang F;Li Y;Dong L;Liu Z;Huang H
Abstract Electro-phonophoresis (EP) has been used as a drug delivery approach in clinical fields. The objective of the present study is to evaluate the skin permeability of isoniazid and rifampin in guinea pigs by EP to provide reference basis for clinical applications of such transdermal delivery system in the treatment of patients with superficial tuberculosis. Isoniazid and rifampin solutions were delivered transdermally with or without EP in health guinea pigs for 0.5 h. Local skin and blood samples were collected serially at 0, 1/2, 1, 2, 4, 6 and 24 h after dosing. Drug concentrations in local skin and blood were evaluated by high-performance liquid chromatography. Isoniazid concentrations in local skin of guinea pigs receiving isoniazid through EP transdermal delivery were significantly higher than in animals receiving only isoniazid with transdermal patch. However, for rifampin, patches alone group presented almost uniform concentration versus time curve with that of EP group, and both groups had concentrations much higher than the therapeutic concentration of the drug over sustainable time. After EP transdermal delivery, the mean peak concentrations of isoniazid and rifampin in skin were 771.0 ± 163.4 μg/mL and 81.2 ± 17.3 μg/mL respectively. Neither isoniazid nor rifampin concentration in blood could be detected (below the lower detection limit of 1 μg/mL) at any time point. The present study showed that application of EP significantly enhanced INH penetration through skin in guinea pigs, while RIF patch alone obtained therapeutic concentration in local skin. Our work suggests several possible medication approaches for efficient treatment of superficial tuberculosis.
登录
查看更多内容
DOI:
10.1073/pnas.90.22.10504
发表时间:
1993-11-15
影响因子:
11.1
作者:
PRAUSNITZ, MR;BOSE, VG;WEAVER, JC
通讯作者:
WEAVER, JC
影响因子:
46.9
作者:
Prausnitz, Mark R.;Langer, Robert
通讯作者:
Langer, Robert
影响因子:
4.2
作者:
Paudel KS;Milewski M;Swadley CL;Brogden NK;Ghosh P;Stinchcomb AL
通讯作者:
Stinchcomb AL
影响因子:
3.7
作者:
Kost, J;Pliquett, U;Weaver, J
通讯作者:
Weaver, J
DOI:
10.1016/j.jconrel.2011.01.006
发表时间:
2011-06-30
期刊:
Journal of controlled release : official journal of the Controlled Release Society
影响因子:
--
作者:
Polat BE;Hart D;Langer R;Blankschtein D
通讯作者:
Blankschtein D